November 6-8, 2024
|
Overview:
MedTech World ‘s MedTech Malta is coming up. If you are attending and want to catch up on current market transactional trends and dynamics, it would be great to find time to talk. I look forward to seeing everyone there; the medtech team at Outcome Capital is prepared to assist and support this next phase of growth and spectacular companies in our industry. |
The New Orleans biotech is currently raising a tiny $8 million Series A to develop its non-opioid painkiller. It keeps costs low by paying employees cash on an hourly basis—but no salaries.
Read MoreOutcome Capital Life Science Market Pulse March 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?